AK106-001616, a Potent and Selective Inhibitor of Cytosolic Phospholipase A2: In Vivo Efficacy for Inflammation, Neuropathic Pain, and Pulmonary Fibrosis-Reference-Cited by-同舟云学术

AK106-001616, a Potent and Selective Inhibitor of Cytosolic Phospholipase A2: In Vivo Efficacy for Inflammation, Neuropathic Pain, and Pulmonary Fibrosis

Published:2019-04-10 Issue:3 Volume:369 Page:511-522
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Shimizu Hirotomo,Ito Akitoshi,Sakurada Katsuhiko,Nakamura Junji,Tanaka Kosuke,Komatsu Masakazu,Takeda Mineko,Saito Kenichi,Endo Yukiko,Kozaki Tomohito,Shoda Motoshi,Kuriyama Hiroshi

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference70 articles.

1. Allen A Carville S McKenna F Guideline Development Group (2018) Diagnosis and management of rheumatoid arthritis in adults: summary of updated NICE guidance. BMJ 362:k3015.

2. Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis

3. Simple method of estimating severity of pulmonary fibrosis on a numerical scale.

4. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels];Baba;Nihon Geka Gakkai Zasshi,1988

5. The pharmacological therapy of chronic neuropathic pain;Binder;Dtsch Arztebl Int,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting the Cytosolic Phospholipase A2–Arachidonic Acid Pathway With Arachidonyl Trifluoromethyl Ketone Attenuates Radiation-Induced Lung Fibrosis;International Journal of Radiation Oncology*Biology*Physics;2023-02

2. Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases;Frontiers in Medicine;2023-01-19

3. Synthesis and pharmacokinetic properties of novel cPLA2α inhibitors with 1-(carboxyalkylpyrrolyl)-3-aryloxypropan-2-one structure;Bioorganic & Medicinal Chemistry;2023-01

4. N-Substituted 4-sulfamoylbenzoic acid derivatives as inhibitors of cytosolic phospholipase A2α;Medicinal Chemistry Research;2022-05-05

5. Glial activation and neuropathic pain;Spinal Cord Injury Pain;2022